CANCER RESEARCH TECHNOLOGY LIMITED
Get an alert when CANCER RESEARCH TECHNOLOGY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2m
+24.6% vs 2025
Net assets
£11m
-30.9% lowest in 3 filed years
Employees
318
+7.1% highest in 3 filed years
Profit before tax
-£5m
+35.3% vs 2025
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £55,157,000 | £39,533,000 | £32,989,000 | -16.6% | |
| Operating profit | £9,293,000 | -£6,146,000 | -£3,186,000 | +48.2% | |
| Profit before tax | £7,319,000 | -£7,694,000 | -£4,975,000 | +35.3% | |
| Net profit | — | -£7,824,000 | -£4,975,000 | +36.4% | |
| Cash | £2,359,000 | £1,613,000 | £2,010,000 | +24.6% | |
| Total assets less current liabilities | £23,904,000 | £16,080,000 | £11,419,000 | -29% | |
| Net assets | £23,902,000 | £16,078,000 | £11,103,000 | -30.9% | |
| Equity | £23,902,000 | £16,078,000 | £11,103,000 | -30.9% | |
| Average employees | 281 | 297 | 318 | +7.1% | |
| Wages | £13,909,000 | £15,346,000 | £17,067,000 | +11.2% | |
| Directors' remuneration | £405,000 | £414,000 | £427,000 | +3.1% | |
| Directors' pension contributions | £31,000 | £32,000 | £34,000 | +6.3% | |
| Highest paid director | £208,578 | £215,818 | £221,669 | +2.7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Operating margin | 16.8% | -15.5% | -9.7% | |
| Net margin | — | -19.8% | -15.1% | |
| Return on capital employed | 38.9% | -38.2% | -27.9% | |
| Gearing (liabilities / total assets) | 49.0% | 53.8% | 63.5% | |
| Current ratio | 1.85x | 1.64x | 1.42x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- CANCER RESEARCH TECHNOLOGY LIMITED 2002-10-01 → present
- CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED 1988-04-06 → 2002-10-01
- CARLTON MEDICAL PRODUCTS LIMITED 1982-07-05 → 1988-04-06
- RESTROSE LIMITED 1982-03-31 → 1982-07-05
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“the directors expect the Company has adequate resources to continue in operational existence for at least 12 months from the authorisation of the financial statements. Accordingly, the financial statements have been prepared on a going concern basis”
Group structure
- CANCER RESEARCH TECHNOLOGY LIMITED · parent
- Cancer Research Ventures Limited 100%
- Cancer Research Horizons Limited 100%
- Cancer Research Scotland Institute Limited 100%
- Cancer Research UK Scotland Institute Limited 100%
- Cancer Research Technology Inc. 100%
Significant events
- “In July 2026, CRT approved the disposal of its investment in Myricx Bio Limited, with completion expected in 2026/27. The sale is considered a non-adjusting event and no adjustment has been made to the amounts recognised in these financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
10 active · 43 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FAIRFIELD, Gillian Amanda | Secretary | 2021-09-28 | — | — |
| BISHOP, Hans Edgar | Director | 2026-03-09 | Apr 1964 | British |
| CHAMBRE, Peter Alan | Director | 2011-10-01 | Nov 1955 | British |
| FOULKES, Iain Walter, Dr | Director | 2013-01-23 | Apr 1971 | British |
| HICKSON, Anthony Charles | Director | 2018-08-07 | Nov 1968 | British |
| JENKINS, Anna Lisa Mary | Director | 2023-04-01 | Jun 1965 | British |
| LENGAUER, Christoph | Director | 2023-04-01 | Mar 1965 | Austrian |
| PRESTON, Heather Elizabeth, Dr | Director | 2026-03-09 | Jan 1966 | British,Canadian |
| THAKRAR, Hitesh | Director | 2025-01-01 | Mar 1962 | British |
| WOOSTER, Richard Francis | Director | 2026-03-09 | Nov 1964 | British,American |
Show 43 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| D'ARCY DOHERTY, Mary, Dr | Secretary | — | 1995-12-20 |
| HINCHLIFFE, Peter Michael | Secretary | 2002-10-01 | 2002-11-04 |
| HIRD, Dean Michael, Doctor | Secretary | 1995-12-20 | 1998-01-09 |
| PICKERING, Christopher David George | Secretary | 2000-07-26 | 2001-01-15 |
| SCOTT, Diane Elizabeth | Secretary | 2002-11-04 | 2003-04-01 |
| SCOTT, Diane Elizabeth | Secretary | 2002-06-11 | 2002-10-01 |
| SEIDEL, David Gary | Secretary | 2001-01-15 | 2002-06-11 |
| WALDRON, Andrew Jonathan | Secretary | 2003-04-01 | 2021-09-28 |
| WALLACE, Roderick Iain | Secretary | 1998-01-09 | 1998-07-29 |
| WILKINSON, John | Secretary | 1998-07-29 | 2000-07-26 |
| BAGSHAWE, Kenneth Dawson, Professor | Director | — | 1991-12-04 |
| BLUNDY, Keith Stuart, Dr | Director | 2002-09-30 | 2016-12-31 |
| CAULCOTT, Celia Ann, Dr | Director | 2003-08-01 | 2006-07-05 |
| DAVIDSON, James | Director | 2002-10-01 | 2003-07-31 |
| DE PEYER, David Charles | Director | — | 1996-04-01 |
| EGAN, John Leopold, Sir | Director | 2002-09-30 | 2004-06-02 |
| FAIRFIELD, Gillian Amanda | Director | 2021-09-28 | 2021-09-28 |
| FODEN, Susan Elizabeth, Dr | Director | — | 2000-05-26 |
| GARLAND, Peter Bryan, Professor | Director | — | 1996-12-31 |
| HARLAND, Deborah, Dr | Director | 2015-09-30 | 2026-03-24 |
| HARRAP, Kenneth Reginald, Professor | Director | — | 1996-12-18 |
| HINCE, Trevor Anthony, Dr | Director | 2001-01-15 | 2002-09-30 |
| JACK, David, Sir | Director | — | 1994-10-20 |
| JONES, Nicholas Clwyd, Professor | Director | 2013-01-23 | 2016-02-25 |
| KUMAR, Harpal Singh | Director | 2002-10-21 | 2018-06-29 |
| L'HULLIER, Phillip John, Dr | Director | 2008-01-29 | 2017-05-09 |
| LEE, Melanie Georgina, Doctor | Director | 2002-09-30 | 2011-09-30 |
| LENNOX, Edwin Samuel, Dr | Director | — | 1996-12-18 |
| MANSFORD, Keith, Doctor | Director | 1997-07-08 | 2001-01-15 |
| MCKERNAN, Ruth, Dr | Director | 2013-05-25 | 2015-03-25 |
| MCVIE, John Gordon, Professor | Director | — | 2002-09-30 |
| MITCHELL, Michelle Elizabeth | Director | 2018-11-22 | 2020-09-30 |
| MOSS, Parker David | Director | 2019-11-29 | 2026-05-27 |
| NEWBIGGING, David Kennedy | Director | 2002-09-30 | 2010-10-31 |
| PERROTT, Hugh Richard Iliff | Director | — | 2001-01-15 |
| PRAGNELL, Michael Patrick | Director | 2010-11-01 | 2016-10-31 |
| RICHARDS, Andrew John Mcglashan, Dr | Director | 2003-08-01 | 2023-07-31 |
| RICHMOND, Mark Henry, Sir | Director | 1996-06-19 | 2002-09-30 |
| RYDER, Hamish, Dr | Director | 2009-01-01 | 2013-02-13 |
| STANWAY, Clive Adrian, Dr | Director | 2002-09-30 | 2013-02-13 |
| THURSTON, Julian Paul | Director | 1995-09-27 | 2001-01-15 |
| TOOZE, John, Dr | Director | 2002-09-30 | 2003-07-31 |
| WARD, John Barrie, Dr | Director | 2006-08-01 | 2013-05-25 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Cancer Research Uk | Corporate entity | Shares 75–100%, Appoints directors | 2022-08-01 | Active |
| Cancer Research Uk | Corporate entity | Shares 75–100%, Appoints directors | 2016-04-06 | Ceased 2022-08-01 |
Filing timeline
Last 20 of 246 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-16 | AA | accounts | Accounts with accounts type full | |
| 2026-06-04 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-07 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-18 | AP01 | officers | Appoint person director company with name date | |
| 2026-03-18 | AP01 | officers | Appoint person director company with name date | |
| 2026-03-18 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-06 | CH01 | officers | Change person director company with change date | |
| 2025-07-29 | AA | accounts | Accounts with accounts type full | |
| 2025-01-22 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-06 | AA | accounts | Accounts with accounts type full | |
| 2024-01-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-14 | TM01 | officers | Termination director company with name termination date | |
| 2023-07-20 | AA | accounts | Accounts with accounts type full | |
| 2023-04-17 | AP01 | officers | Appoint person director company with name date | |
| 2023-04-14 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-19 | AA | accounts | Accounts with accounts type full | |
| 2022-08-11 | PSC02 | persons-with-significant-control | Notification of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 3
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.